

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of memory T cell differentiation (GO:0043380) | 8.31395949 |
| 2 | interkinetic nuclear migration (GO:0022027) | 7.30454638 |
| 3 | positive regulation of natural killer cell differentiation (GO:0032825) | 6.32574128 |
| 4 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 6.15014378 |
| 5 | iron-sulfur cluster assembly (GO:0016226) | 5.60566065 |
| 6 | metallo-sulfur cluster assembly (GO:0031163) | 5.60566065 |
| 7 | ubiquinone biosynthetic process (GO:0006744) | 5.17892539 |
| 8 | L-alpha-amino acid transmembrane transport (GO:1902475) | 5.06090846 |
| 9 | piRNA metabolic process (GO:0034587) | 4.77237079 |
| 10 | seminiferous tubule development (GO:0072520) | 4.76269997 |
| 11 | regulation of chemokine biosynthetic process (GO:0045073) | 4.66279441 |
| 12 | ubiquinone metabolic process (GO:0006743) | 4.47658359 |
| 13 | regulation of natural killer cell differentiation (GO:0032823) | 4.40679748 |
| 14 | tyrosine phosphorylation of STAT protein (GO:0007260) | 4.40184985 |
| 15 | cellular ketone body metabolic process (GO:0046950) | 4.30682842 |
| 16 | histone H3-K9 methylation (GO:0051567) | 4.23659764 |
| 17 | GPI anchor biosynthetic process (GO:0006506) | 4.18031702 |
| 18 | ribosomal small subunit assembly (GO:0000028) | 4.16599920 |
| 19 | quinone biosynthetic process (GO:1901663) | 4.15766431 |
| 20 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 4.08817200 |
| 21 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.05241944 |
| 22 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.04469692 |
| 23 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 4.03706437 |
| 24 | regulation of activation of Janus kinase activity (GO:0010533) | 3.94297103 |
| 25 | negative regulation of type 2 immune response (GO:0002829) | 3.94250883 |
| 26 | GPI anchor metabolic process (GO:0006505) | 3.85871975 |
| 27 | forebrain morphogenesis (GO:0048853) | 3.84110390 |
| 28 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.79999694 |
| 29 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.79999694 |
| 30 | positive regulation of cell fate commitment (GO:0010455) | 3.79325343 |
| 31 | ketone body metabolic process (GO:1902224) | 3.78838201 |
| 32 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.75844517 |
| 33 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.71477000 |
| 34 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 3.68233186 |
| 35 | UMP biosynthetic process (GO:0006222) | 3.68233186 |
| 36 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 3.68233186 |
| 37 | UMP metabolic process (GO:0046049) | 3.68233186 |
| 38 | actin nucleation (GO:0045010) | 3.61538734 |
| 39 | maternal behavior (GO:0042711) | 3.60728686 |
| 40 | rRNA methylation (GO:0031167) | 3.60678589 |
| 41 | regulation of interleukin-13 production (GO:0032656) | 3.60655517 |
| 42 | neutrophil mediated immunity (GO:0002446) | 3.58371521 |
| 43 | parental behavior (GO:0060746) | 3.58089323 |
| 44 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.54634905 |
| 45 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.42292354 |
| 46 | inositol phosphate dephosphorylation (GO:0046855) | 3.42292354 |
| 47 | positive regulation of natural killer cell activation (GO:0032816) | 3.37767861 |
| 48 | histone H3-K9 modification (GO:0061647) | 3.33542817 |
| 49 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.31369300 |
| 50 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.27107429 |
| 51 | ribosomal large subunit biogenesis (GO:0042273) | 3.24023732 |
| 52 | regulation of G0 to G1 transition (GO:0070316) | 3.23078282 |
| 53 | rRNA modification (GO:0000154) | 3.23012574 |
| 54 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 3.21011829 |
| 55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.17969727 |
| 56 | positive regulation of defense response to virus by host (GO:0002230) | 3.16863409 |
| 57 | nucleotide salvage (GO:0043173) | 3.16838280 |
| 58 | regulation of growth of symbiont in host (GO:0044126) | 3.14552300 |
| 59 | negative regulation of growth of symbiont in host (GO:0044130) | 3.14552300 |
| 60 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.14552300 |
| 61 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.14552300 |
| 62 | primitive streak formation (GO:0090009) | 3.09341410 |
| 63 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.04353102 |
| 64 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.03895504 |
| 65 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.97477072 |
| 66 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.96505159 |
| 67 | viral transcription (GO:0019083) | 2.95012441 |
| 68 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.94507431 |
| 69 | translational termination (GO:0006415) | 2.93787162 |
| 70 | inositol phosphate catabolic process (GO:0071545) | 2.93099075 |
| 71 | disruption of cells of other organism (GO:0044364) | 2.90331154 |
| 72 | killing of cells of other organism (GO:0031640) | 2.90331154 |
| 73 | negative regulation of chemokine production (GO:0032682) | 2.89695679 |
| 74 | positive regulation of B cell differentiation (GO:0045579) | 2.89564759 |
| 75 | neutrophil activation involved in immune response (GO:0002283) | 2.89298031 |
| 76 | mRNA cleavage (GO:0006379) | 2.87332587 |
| 77 | hepatocyte differentiation (GO:0070365) | 2.86904366 |
| 78 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.85470515 |
| 79 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.84822762 |
| 80 | male meiosis I (GO:0007141) | 2.83070269 |
| 81 | definitive hemopoiesis (GO:0060216) | 2.82794304 |
| 82 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.78786926 |
| 83 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.75759830 |
| 84 | glycolipid biosynthetic process (GO:0009247) | 2.75340695 |
| 85 | cellular response to reactive nitrogen species (GO:1902170) | 2.73741199 |
| 86 | induction of positive chemotaxis (GO:0050930) | 2.73618257 |
| 87 | positive regulation of meiosis (GO:0045836) | 2.71949357 |
| 88 | oocyte maturation (GO:0001556) | 2.70714004 |
| 89 | GDP-mannose metabolic process (GO:0019673) | 2.68312525 |
| 90 | RNA polyadenylation (GO:0043631) | 2.68002730 |
| 91 | mRNA polyadenylation (GO:0006378) | 2.67938709 |
| 92 | regulation of hypersensitivity (GO:0002883) | 2.67521987 |
| 93 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.66551737 |
| 94 | response to interferon-beta (GO:0035456) | 2.61653142 |
| 95 | meiosis I (GO:0007127) | 2.61064675 |
| 96 | Peyers patch development (GO:0048541) | 2.60879931 |
| 97 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.60879931 |
| 98 | response to fungus (GO:0009620) | 2.60617425 |
| 99 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.57971083 |
| 100 | cytidine catabolic process (GO:0006216) | 2.57242904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.59925805 |
| 2 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.71259474 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.26640951 |
| 4 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.20100507 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 3.04849229 |
| 6 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.31909358 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.31278160 |
| 8 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16975662 |
| 9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.13693083 |
| 10 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.08034165 |
| 11 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.01646359 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.01062098 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.98708135 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.94792499 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.84775709 |
| 16 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.84145685 |
| 17 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.82684842 |
| 18 | FUS_26573619_Chip-Seq_HEK293_Human | 1.81455259 |
| 19 | UTX_26944678_Chip-Seq_JUKART_Human | 1.81014806 |
| 20 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.74888388 |
| 21 | TP53_16413492_ChIP-PET_HCT116_Human | 1.72967988 |
| 22 | GATA3_26560356_Chip-Seq_TH2_Human | 1.72516181 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 1.69793486 |
| 24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.69645764 |
| 25 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.67214171 |
| 26 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.61893303 |
| 27 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61733140 |
| 28 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.61476065 |
| 29 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.55999224 |
| 30 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53702950 |
| 31 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.49476832 |
| 32 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.47217161 |
| 33 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.45769372 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45456634 |
| 35 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.44546306 |
| 36 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.43809590 |
| 37 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.41724173 |
| 38 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.41393252 |
| 39 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.39473850 |
| 40 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.39473850 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.38679533 |
| 42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.37909830 |
| 43 | NCOR_22424771_ChIP-Seq_293T_Human | 1.36075858 |
| 44 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.35628845 |
| 45 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.34602309 |
| 46 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.34571406 |
| 47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.32334532 |
| 48 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.31951233 |
| 49 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.28283655 |
| 50 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.27112723 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26704359 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26004462 |
| 53 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 1.25603527 |
| 54 | P300_27268052_Chip-Seq_Bcells_Human | 1.25399273 |
| 55 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.24339348 |
| 56 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23840435 |
| 57 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.22610662 |
| 58 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22037543 |
| 59 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.21711348 |
| 60 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.21711348 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19317775 |
| 62 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.18949588 |
| 63 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.18733014 |
| 64 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18315813 |
| 65 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.16278976 |
| 66 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.15495297 |
| 67 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.15460504 |
| 68 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.14994319 |
| 69 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.13096950 |
| 70 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.12515977 |
| 71 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.12515977 |
| 72 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.12515977 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12121879 |
| 74 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.11776383 |
| 75 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.11296424 |
| 76 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.11268973 |
| 77 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10865464 |
| 78 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.10748764 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10541860 |
| 80 | AR_20517297_ChIP-Seq_VCAP_Human | 1.10441370 |
| 81 | MYB_26560356_Chip-Seq_TH1_Human | 1.07926060 |
| 82 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.07542299 |
| 83 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05655892 |
| 84 | GATA3_26560356_Chip-Seq_TH1_Human | 1.04740726 |
| 85 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.04593892 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04440008 |
| 87 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.03233009 |
| 88 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.02205730 |
| 89 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01918940 |
| 90 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00736613 |
| 91 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00449664 |
| 92 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.00173822 |
| 93 | P68_20966046_ChIP-Seq_HELA_Human | 0.99975839 |
| 94 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.99258863 |
| 95 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.99197173 |
| 96 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.99132322 |
| 97 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98679194 |
| 98 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98543774 |
| 99 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95553781 |
| 100 | SPI1_23127762_ChIP-Seq_K562_Human | 0.94161801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 6.25511764 |
| 2 | MP0000569_abnormal_digit_pigmentation | 5.01249179 |
| 3 | MP0005174_abnormal_tail_pigmentation | 4.33024511 |
| 4 | MP0006292_abnormal_olfactory_placode | 3.89282649 |
| 5 | MP0002163_abnormal_gland_morphology | 3.47805260 |
| 6 | MP0000372_irregular_coat_pigmentation | 3.17286658 |
| 7 | MP0000015_abnormal_ear_pigmentation | 2.91539547 |
| 8 | MP0010368_abnormal_lymphatic_system | 2.90208429 |
| 9 | MP0005397_hematopoietic_system_phenotyp | 2.49639721 |
| 10 | MP0001545_abnormal_hematopoietic_system | 2.49639721 |
| 11 | MP0001188_hyperpigmentation | 2.41111309 |
| 12 | MP0002132_abnormal_respiratory_system | 2.23421967 |
| 13 | MP0009764_decreased_sensitivity_to | 2.19579257 |
| 14 | MP0002822_catalepsy | 2.06808056 |
| 15 | MP0005084_abnormal_gallbladder_morpholo | 2.04240327 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.01001725 |
| 17 | MP0005645_abnormal_hypothalamus_physiol | 1.89648927 |
| 18 | MP0009785_altered_susceptibility_to | 1.87015735 |
| 19 | MP0002095_abnormal_skin_pigmentation | 1.72823677 |
| 20 | MP0010155_abnormal_intestine_physiology | 1.68758817 |
| 21 | MP0001986_abnormal_taste_sensitivity | 1.66346104 |
| 22 | MP0005379_endocrine/exocrine_gland_phen | 1.65612188 |
| 23 | MP0001800_abnormal_humoral_immune | 1.58355845 |
| 24 | MP0008058_abnormal_DNA_repair | 1.57121856 |
| 25 | MP0006082_CNS_inflammation | 1.55816041 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 1.54015926 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.53385514 |
| 28 | MP0005671_abnormal_response_to | 1.52611910 |
| 29 | MP0000681_abnormal_thyroid_gland | 1.47700574 |
| 30 | MP0002928_abnormal_bile_duct | 1.46096883 |
| 31 | MP0002160_abnormal_reproductive_system | 1.44444325 |
| 32 | MP0009697_abnormal_copulation | 1.41576988 |
| 33 | MP0005025_abnormal_response_to | 1.41172446 |
| 34 | MP0003763_abnormal_thymus_physiology | 1.39443371 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.37633424 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.34873914 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.28024116 |
| 38 | MP0005000_abnormal_immune_tolerance | 1.25910145 |
| 39 | MP0003436_decreased_susceptibility_to | 1.23648262 |
| 40 | MP0009765_abnormal_xenobiotic_induced | 1.23508226 |
| 41 | MP0002938_white_spotting | 1.21970469 |
| 42 | MP0002723_abnormal_immune_serum | 1.21108390 |
| 43 | MP0009384_cardiac_valve_regurgitation | 1.20201972 |
| 44 | MP0005389_reproductive_system_phenotype | 1.18079841 |
| 45 | MP0002398_abnormal_bone_marrow | 1.10928184 |
| 46 | MP0003136_yellow_coat_color | 1.09379658 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.09328296 |
| 48 | MP0002420_abnormal_adaptive_immunity | 1.09278388 |
| 49 | MP0008995_early_reproductive_senescence | 1.07734403 |
| 50 | MP0001819_abnormal_immune_cell | 1.05297996 |
| 51 | MP0004043_abnormal_pH_regulation | 1.02178155 |
| 52 | MP0005164_abnormal_response_to | 1.01898126 |
| 53 | MP0001879_abnormal_lymphatic_vessel | 1.01698446 |
| 54 | MP0001968_abnormal_touch/_nociception | 1.01147028 |
| 55 | MP0001845_abnormal_inflammatory_respons | 0.99399065 |
| 56 | MP0000716_abnormal_immune_system | 0.98642024 |
| 57 | MP0002419_abnormal_innate_immunity | 0.98168610 |
| 58 | MP0004484_altered_response_of | 0.96291297 |
| 59 | MP0008874_decreased_physiological_sensi | 0.95186351 |
| 60 | MP0002735_abnormal_chemical_nociception | 0.94538195 |
| 61 | MP0005551_abnormal_eye_electrophysiolog | 0.93779922 |
| 62 | MP0000703_abnormal_thymus_morphology | 0.93759993 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 0.93728568 |
| 64 | MP0004947_skin_inflammation | 0.92566635 |
| 65 | MP0002722_abnormal_immune_system | 0.90925146 |
| 66 | MP0009763_increased_sensitivity_to | 0.88885152 |
| 67 | MP0008873_increased_physiological_sensi | 0.87776973 |
| 68 | MP0002733_abnormal_thermal_nociception | 0.86687629 |
| 69 | MP0002452_abnormal_antigen_presenting | 0.86004583 |
| 70 | MP0001929_abnormal_gametogenesis | 0.85515425 |
| 71 | MP0000689_abnormal_spleen_morphology | 0.81564689 |
| 72 | MP0004147_increased_porphyrin_level | 0.79688169 |
| 73 | MP0002009_preneoplasia | 0.79334240 |
| 74 | MP0006138_congestive_heart_failure | 0.78464706 |
| 75 | MP0003828_pulmonary_edema | 0.78397574 |
| 76 | MP0001835_abnormal_antigen_presentation | 0.78162895 |
| 77 | MP0005410_abnormal_fertilization | 0.76524591 |
| 78 | MP0008469_abnormal_protein_level | 0.76180894 |
| 79 | MP0002429_abnormal_blood_cell | 0.75778213 |
| 80 | MP0001485_abnormal_pinna_reflex | 0.74780864 |
| 81 | MP0003011_delayed_dark_adaptation | 0.74388740 |
| 82 | MP0004130_abnormal_muscle_cell | 0.74195497 |
| 83 | MP0001970_abnormal_pain_threshold | 0.74158822 |
| 84 | MP0008872_abnormal_physiological_respon | 0.73889789 |
| 85 | MP0005387_immune_system_phenotype | 0.73620790 |
| 86 | MP0001790_abnormal_immune_system | 0.73620790 |
| 87 | MP0005646_abnormal_pituitary_gland | 0.73010167 |
| 88 | MP0003787_abnormal_imprinting | 0.71044900 |
| 89 | MP0005367_renal/urinary_system_phenotyp | 0.69298651 |
| 90 | MP0000516_abnormal_urinary_system | 0.69298651 |
| 91 | MP0009333_abnormal_splenocyte_physiolog | 0.66744526 |
| 92 | MP0005503_abnormal_tendon_morphology | 0.66231580 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 0.66213108 |
| 94 | MP0005670_abnormal_white_adipose | 0.65028893 |
| 95 | MP0003698_abnormal_male_reproductive | 0.64982248 |
| 96 | MP0004883_abnormal_blood_vessel | 0.63477410 |
| 97 | MP0002102_abnormal_ear_morphology | 0.63319156 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.61432825 |
| 99 | MP0003123_paternal_imprinting | 0.60045197 |
| 100 | MP0003724_increased_susceptibility_to | 0.59368136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thrombocytosis (HP:0001894) | 6.62605954 |
| 2 | B lymphocytopenia (HP:0010976) | 4.73229742 |
| 3 | Abnormality of B cell number (HP:0010975) | 4.54999064 |
| 4 | Eosinophilia (HP:0001880) | 3.91975389 |
| 5 | Acute hepatic failure (HP:0006554) | 3.50752304 |
| 6 | Granulocytopenia (HP:0001913) | 3.47443751 |
| 7 | Cerebellar dysplasia (HP:0007033) | 3.44319565 |
| 8 | Gingival bleeding (HP:0000225) | 3.42490666 |
| 9 | Spontaneous abortion (HP:0005268) | 3.31885066 |
| 10 | Type I transferrin isoform profile (HP:0003642) | 3.27240847 |
| 11 | Hypoplasia of the pons (HP:0012110) | 3.17620305 |
| 12 | Abnormality of eosinophils (HP:0001879) | 3.11970380 |
| 13 | Inflammation of the large intestine (HP:0002037) | 3.06356195 |
| 14 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.03367743 |
| 15 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.03367743 |
| 16 | Abnormal protein glycosylation (HP:0012346) | 3.03367743 |
| 17 | Abnormal glycosylation (HP:0012345) | 3.03367743 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 3.03165842 |
| 19 | Increased intramyocellular lipid droplets (HP:0012240) | 3.00718214 |
| 20 | T lymphocytopenia (HP:0005403) | 2.96360943 |
| 21 | Abnormality of T cell number (HP:0011839) | 2.94154778 |
| 22 | Gastrointestinal inflammation (HP:0004386) | 2.87284138 |
| 23 | Autoimmune hemolytic anemia (HP:0001890) | 2.86523662 |
| 24 | Type II lissencephaly (HP:0007260) | 2.85642226 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 2.82173560 |
| 26 | Choroideremia (HP:0001139) | 2.81224059 |
| 27 | Renal cortical cysts (HP:0000803) | 2.80875856 |
| 28 | Fatigue (HP:0012378) | 2.72324512 |
| 29 | Tinnitus (HP:0000360) | 2.69419930 |
| 30 | Abnormality of the pons (HP:0007361) | 2.66917013 |
| 31 | Leukocytosis (HP:0001974) | 2.66669291 |
| 32 | Increased muscle lipid content (HP:0009058) | 2.66029281 |
| 33 | Agammaglobulinemia (HP:0004432) | 2.65780027 |
| 34 | Pancreatic fibrosis (HP:0100732) | 2.64867340 |
| 35 | True hermaphroditism (HP:0010459) | 2.64617885 |
| 36 | Severe visual impairment (HP:0001141) | 2.59920613 |
| 37 | Reduced antithrombin III activity (HP:0001976) | 2.59875396 |
| 38 | Febrile seizures (HP:0002373) | 2.52437734 |
| 39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.51177600 |
| 40 | Hypergammaglobulinemia (HP:0010702) | 2.51100812 |
| 41 | Diastasis recti (HP:0001540) | 2.47403526 |
| 42 | Pancreatic cysts (HP:0001737) | 2.46574536 |
| 43 | Palpebral edema (HP:0100540) | 2.42816562 |
| 44 | Congenital primary aphakia (HP:0007707) | 2.40986411 |
| 45 | Panhypogammaglobulinemia (HP:0003139) | 2.40009296 |
| 46 | Colitis (HP:0002583) | 2.38584328 |
| 47 | Exertional dyspnea (HP:0002875) | 2.35358112 |
| 48 | Brushfield spots (HP:0001088) | 2.33316713 |
| 49 | Gait imbalance (HP:0002141) | 2.31842578 |
| 50 | Neurodegeneration (HP:0002180) | 2.30906883 |
| 51 | Abnormal hemoglobin (HP:0011902) | 2.24122599 |
| 52 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.23301259 |
| 53 | Retinal atrophy (HP:0001105) | 2.22648820 |
| 54 | Short tibia (HP:0005736) | 2.21283768 |
| 55 | Respiratory difficulties (HP:0002880) | 2.21280567 |
| 56 | Spontaneous hematomas (HP:0007420) | 2.21214442 |
| 57 | Concave nail (HP:0001598) | 2.18357391 |
| 58 | Nephrogenic diabetes insipidus (HP:0009806) | 2.17022936 |
| 59 | Abnormality of T cells (HP:0002843) | 2.13064744 |
| 60 | Medial flaring of the eyebrow (HP:0010747) | 2.12810483 |
| 61 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.10959448 |
| 62 | Nasal polyposis (HP:0100582) | 2.09460733 |
| 63 | Spastic paraparesis (HP:0002313) | 2.07875733 |
| 64 | Encephalitis (HP:0002383) | 2.07544546 |
| 65 | Epistaxis (HP:0000421) | 2.02445394 |
| 66 | Preauricular pit (HP:0004467) | 2.01019605 |
| 67 | Periauricular skin pits (HP:0100277) | 2.01019605 |
| 68 | Ketoacidosis (HP:0001993) | 1.99949042 |
| 69 | Chest pain (HP:0100749) | 1.99167203 |
| 70 | Stenosis of the external auditory canal (HP:0000402) | 1.98334082 |
| 71 | Poor coordination (HP:0002370) | 1.97232269 |
| 72 | Acute lymphatic leukemia (HP:0006721) | 1.95897204 |
| 73 | Retinal dysplasia (HP:0007973) | 1.95086071 |
| 74 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.95061731 |
| 75 | IgG deficiency (HP:0004315) | 1.94992259 |
| 76 | Albinism (HP:0001022) | 1.92833074 |
| 77 | Brittle hair (HP:0002299) | 1.92305394 |
| 78 | Decreased central vision (HP:0007663) | 1.92001837 |
| 79 | Abnormality of alanine metabolism (HP:0010916) | 1.91490530 |
| 80 | Hyperalaninemia (HP:0003348) | 1.91490530 |
| 81 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.91490530 |
| 82 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.86470909 |
| 83 | Hematochezia (HP:0002573) | 1.85428306 |
| 84 | Absent speech (HP:0001344) | 1.84184605 |
| 85 | Redundant skin (HP:0001582) | 1.83846162 |
| 86 | Increased IgM level (HP:0003496) | 1.83673936 |
| 87 | Sensorimotor neuropathy (HP:0007141) | 1.83240086 |
| 88 | Tachypnea (HP:0002789) | 1.81964111 |
| 89 | Dyschromatopsia (HP:0007641) | 1.80863383 |
| 90 | Recurrent bacterial skin infections (HP:0005406) | 1.80662077 |
| 91 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.80423835 |
| 92 | Hepatocellular necrosis (HP:0001404) | 1.79963801 |
| 93 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.77898425 |
| 94 | Obstructive lung disease (HP:0006536) | 1.77750613 |
| 95 | Chronic obstructive pulmonary disease (HP:0006510) | 1.77750613 |
| 96 | Cystic liver disease (HP:0006706) | 1.76852760 |
| 97 | Asthma (HP:0002099) | 1.75690810 |
| 98 | Severe combined immunodeficiency (HP:0004430) | 1.75590530 |
| 99 | Abnormality of lateral ventricle (HP:0030047) | 1.73758111 |
| 100 | Recurrent abscess formation (HP:0002722) | 1.72642689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZAK | 5.59604494 |
| 2 | TIE1 | 5.13276204 |
| 3 | TEC | 3.07208712 |
| 4 | RIPK4 | 3.02248272 |
| 5 | STK24 | 2.96503166 |
| 6 | BMPR2 | 2.83882089 |
| 7 | ADRBK2 | 2.77772145 |
| 8 | MAP3K5 | 2.56625376 |
| 9 | MAP3K13 | 2.45059327 |
| 10 | STK38L | 2.38629011 |
| 11 | RPS6KA4 | 2.28031309 |
| 12 | TESK2 | 2.15268650 |
| 13 | VRK1 | 2.10858895 |
| 14 | TLK1 | 2.03184653 |
| 15 | KDR | 1.90636911 |
| 16 | VRK2 | 1.76366563 |
| 17 | PIM2 | 1.75662388 |
| 18 | IKBKB | 1.72604766 |
| 19 | JAK3 | 1.70228407 |
| 20 | KIT | 1.67867335 |
| 21 | TAOK3 | 1.65052496 |
| 22 | ITK | 1.56912090 |
| 23 | MELK | 1.41405098 |
| 24 | GRK7 | 1.39126960 |
| 25 | TBK1 | 1.33412619 |
| 26 | IKBKE | 1.26747542 |
| 27 | PIM1 | 1.25594692 |
| 28 | BRSK2 | 1.19709891 |
| 29 | PRKCQ | 1.16604260 |
| 30 | EIF2AK3 | 1.10904728 |
| 31 | RPS6KA5 | 1.06311277 |
| 32 | STK3 | 1.05613054 |
| 33 | BMPR1B | 0.98747722 |
| 34 | CAMKK2 | 0.98442413 |
| 35 | NTRK2 | 0.98173534 |
| 36 | MAP3K14 | 0.97461310 |
| 37 | TYK2 | 0.96753906 |
| 38 | NLK | 0.96622275 |
| 39 | GRK1 | 0.94143359 |
| 40 | MATK | 0.90985458 |
| 41 | DAPK3 | 0.89447841 |
| 42 | BTK | 0.89229568 |
| 43 | DAPK1 | 0.88867593 |
| 44 | MAP2K7 | 0.85387090 |
| 45 | TXK | 0.83450954 |
| 46 | JAK1 | 0.77886005 |
| 47 | ADRBK1 | 0.77814603 |
| 48 | TRIM28 | 0.76954634 |
| 49 | BCKDK | 0.76453652 |
| 50 | JAK2 | 0.75730560 |
| 51 | PDK2 | 0.74283900 |
| 52 | FLT3 | 0.73334735 |
| 53 | SIK3 | 0.67772253 |
| 54 | CSNK1A1 | 0.66589269 |
| 55 | GSK3A | 0.64374848 |
| 56 | SYK | 0.63801935 |
| 57 | CSNK1G1 | 0.63598596 |
| 58 | FRK | 0.63456614 |
| 59 | CHUK | 0.62775223 |
| 60 | NUAK1 | 0.60464839 |
| 61 | SCYL2 | 0.59558849 |
| 62 | FES | 0.58428143 |
| 63 | LCK | 0.56517884 |
| 64 | DAPK2 | 0.55755871 |
| 65 | BCR | 0.55669031 |
| 66 | INSRR | 0.48996850 |
| 67 | DYRK1A | 0.48446056 |
| 68 | ABL1 | 0.45894077 |
| 69 | MAP3K12 | 0.44136910 |
| 70 | CHEK2 | 0.43815795 |
| 71 | CDK3 | 0.43776577 |
| 72 | PIK3CG | 0.41796251 |
| 73 | PRKCH | 0.41586318 |
| 74 | LYN | 0.39223504 |
| 75 | GRK5 | 0.38609817 |
| 76 | MAP3K7 | 0.38424269 |
| 77 | RPS6KA6 | 0.37133168 |
| 78 | TGFBR1 | 0.35857281 |
| 79 | PDK1 | 0.35644517 |
| 80 | RPS6KL1 | 0.35364624 |
| 81 | RPS6KC1 | 0.35364624 |
| 82 | RPS6KB1 | 0.34745269 |
| 83 | CAMK2B | 0.34628225 |
| 84 | NEK2 | 0.33963879 |
| 85 | RPS6KB2 | 0.33160931 |
| 86 | AURKA | 0.33142206 |
| 87 | GRK6 | 0.32386420 |
| 88 | PRKCA | 0.31364584 |
| 89 | WNK3 | 0.27060525 |
| 90 | PKN1 | 0.26692625 |
| 91 | CDK6 | 0.26477305 |
| 92 | PDPK1 | 0.25311490 |
| 93 | MAP4K2 | 0.24803213 |
| 94 | CAMK1 | 0.24379563 |
| 95 | ALK | 0.24173359 |
| 96 | EIF2AK2 | 0.23902031 |
| 97 | HCK | 0.23865999 |
| 98 | CAMK2D | 0.23403793 |
| 99 | IGF1R | 0.22088051 |
| 100 | TAF1 | 0.21477517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.32371794 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 4.19652650 |
| 3 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.61089430 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.20882407 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.05771963 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 2.74888242 |
| 7 | Basal transcription factors_Homo sapiens_hsa03022 | 2.42256717 |
| 8 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.19966236 |
| 9 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.10978029 |
| 10 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.98686129 |
| 11 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.97637669 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.93353807 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 1.87954958 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.73319621 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.63478753 |
| 16 | ABC transporters_Homo sapiens_hsa02010 | 1.60940897 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.44280313 |
| 18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.42551971 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.40916406 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40313899 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.36871570 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.34849072 |
| 23 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.30570471 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.29566448 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.28989744 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.21679360 |
| 27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.21294712 |
| 28 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.20385804 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.20351868 |
| 30 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.19631183 |
| 31 | Olfactory transduction_Homo sapiens_hsa04740 | 1.18553448 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.17438100 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.16678255 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16210321 |
| 35 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.10864128 |
| 36 | Proteasome_Homo sapiens_hsa03050 | 1.04871550 |
| 37 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.04305722 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01484932 |
| 39 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.99367934 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.98096334 |
| 41 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.95212379 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.94644113 |
| 43 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.93214366 |
| 44 | Parkinsons disease_Homo sapiens_hsa05012 | 0.91660764 |
| 45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.91498045 |
| 46 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91419868 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.88490582 |
| 48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.86585009 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86101417 |
| 50 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.84438674 |
| 51 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83048422 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80853222 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.78444521 |
| 54 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.77912245 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77191671 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75970398 |
| 57 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.75945190 |
| 58 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.74957037 |
| 59 | Alzheimers disease_Homo sapiens_hsa05010 | 0.74903019 |
| 60 | Huntingtons disease_Homo sapiens_hsa05016 | 0.73893375 |
| 61 | Allograft rejection_Homo sapiens_hsa05330 | 0.73045294 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.70453825 |
| 63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69888931 |
| 64 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.67176718 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.65827087 |
| 66 | Histidine metabolism_Homo sapiens_hsa00340 | 0.65029387 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 0.64361692 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64277948 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62747721 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.61095460 |
| 71 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60738345 |
| 72 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.60493490 |
| 73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.58642332 |
| 74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57094080 |
| 75 | Salivary secretion_Homo sapiens_hsa04970 | 0.56030130 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.56028126 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55609379 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54192609 |
| 79 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52784068 |
| 80 | Nicotine addiction_Homo sapiens_hsa05033 | 0.52444425 |
| 81 | Taste transduction_Homo sapiens_hsa04742 | 0.51843222 |
| 82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51377082 |
| 83 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.51152577 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48959251 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48441630 |
| 86 | Measles_Homo sapiens_hsa05162 | 0.46890461 |
| 87 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.44285464 |
| 88 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.43841522 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42312928 |
| 90 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.42257011 |
| 91 | Leishmaniasis_Homo sapiens_hsa05140 | 0.40691835 |
| 92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39052020 |
| 93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38974055 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.38875152 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38718392 |
| 96 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38475179 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.36353078 |
| 98 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.36255292 |
| 99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35936348 |
| 100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35382559 |

